Emedgene Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Emedgene's estimated annual revenue is currently $3.7M per year.(i)
  • Emedgene's estimated revenue per employee is $112,000

Employee Data

  • Emedgene has 33 Employees.(i)
  • Emedgene grew their employee count by -15% last year.

Emedgene's People

NameTitleEmail/Phone
1
CEO & Co-founderReveal Email/Phone
2
CSO & Co-founderReveal Email/Phone
3
CTO & Co-founderReveal Email/Phone
4
Office ManagerReveal Email/Phone
5
Senior Software EngineerReveal Email/Phone
6
Clinical Genomics ScientistReveal Email/Phone
7
Full Stack EngineerReveal Email/Phone
8
Strategy ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M17N/AN/AN/A
#2
$0.6M80%N/AN/A
#3
$13.2M946%N/AN/A
#4
$78.4M4410%$6.8MN/A
#5
$12M86-1%N/AN/A
#6
$66.1M372-3%$131.5MN/A
#7
$0.6M8-50%N/AN/A
#8
$0.3M433%N/AN/A
#9
$0.6M9N/AN/AN/A
#10
$2.6M27N/AN/AN/A
Add Company

What Is Emedgene?

Emedgene is the world's first completely automated genetic interpretation platform. We're applying the most advanced AI technologies in order to dramatically scale genetic interpretation and discovery. Clinical labs using Emedgene improve dry lab efficiency, reducing time spent on interpretation and reporting, increasing yield and scaling their genomic interpretation operation. Research organizations using Emedgene accelerate genomic-driven discovery through the application of end-to-end AI, from NLP of publications, through custom machine learning algorithms.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$3.7M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Emedgene News

2022-03-22 - DNA sequencing giant Illumina to establish Center of ...

"Using genomics artificial intelligence platforms such as Illumina's Emedgene shortens relevant lists of potentially causative variants,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M3338%$27M
#2
$5.3M3374%$3.2M
#3
$3.8M33-3%N/A
#4
$4.2M333%N/A
#5
$5.1M33-15%N/A